Montu Group
Montu Group is a privately-held medical cannabis company founded in 2019 and headquartered in Melbourne, Australia, operating locally integrated healthcare ecosystems across Europe and Asia-Pacific that facilitate end-to-end patient access to medical cannabis products via healthcare provider networks.
- Company typePrivate
- Founded2019
- HeadquartersMelbourne, Australia
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What Montu Group does
Montu Group is a privately-held medical cannabis company founded in 2019 and headquartered in Melbourne, Australia, with operations spanning Europe and Asia-Pacific. The company operates locally integrated healthcare ecosystems that streamline the patient experience end-to-end, facilitating access to medical cannabis for patients in regulated markets through healthcare provider networks. Germany and Australia are positioned as the company's largest growth markets outside of North America, with the UK also emerging as a market following the establishment of the Alternaleaf clinic.
Montu's core business model is a transaction-fee revenue structure, where the company earns revenue by facilitating access to cannabis products through regulated healthcare channels. The company targets medical cannabis patients who face access barriers, supply reliability issues, and limited physician understanding of cannabis therapies. Beyond patient access, Montu positions itself as supporting the broader medical community in understanding emerging cannabis treatment applications, with international and local partnerships supporting product innovation, regulatory compliance, and market development.
Montu operates with an explicitly long-term horizon focused on regulatory compliance and building relationships with regulatory bodies as cannabis laws evolve across international markets. With a headcount of 501-1000 employees, the company is materially scaled relative to most regional cannabis operators. No proprietary technology stack or digital platform architecture was disclosed in available source material, suggesting the business is operationally intensive rather than technology-led. The company addresses what it identifies as a $100Bn+ global cannabis market opportunity, with medical cannabis now legalised in 50+ countries.
Montu Group firmographics
Firmographics- Name
- Montu Group
- Legal name
- Montu Group
- Website
- https://montugroup.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Montu Group is a privately-held medical cannabis company founded in 2019 and headquartered in Melbourne, Australia, operating locally integrated healthcare ecosystems across Europe and Asia-Pacific that facilitate end-to-end patient access to medical cannabis products via healthcare provider networks.
- Ownership category
- akta.pro rank
Montu Group industry classification
Industry- Product category
- Medical Cannabis
- akta.pro primary industry
- Medical Cannabis Dispensaries (CRANAFAB)
- akta.pro secondary industries
- Medical Cannabis Delivery & Online Ordering (CRANAGAG), Cannabis Subscription & Membership Delivery Programs (CRANAGAI), Third-Party White-Label Ordering & Delivery Platforms (SaaS + Logistics) (CRANAGAF)
Keywords
Where Montu Group is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Markets served
Montu Group business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D
Revenue model
- Cannabis Product Sales: Revenue generated through facilitation of access to cannabis products via their locally integrated healthcare ecosystems, serving patients in Europe and Asia-Pacific markets.
Go-to-market motion1 record
Distribution channels1 record
Montu Group product offering
Product offeringCore offering
Montu Group facilitates access to medical cannabis products for patients through locally integrated ecosystems that streamline the end-to-end patient experience across Europe and Asia-Pacific markets. The company supports the medical community in understanding cannabis therapies, partners internationally and locally for product innovation and regulatory compliance, and operates with a long-term horizon in regulated cannabis markets, with Germany and Australia as its primary growth markets.
Product overview
Montu Group is a cannabis company operating across Europe and Asia-Pacific that facilitates access to medical cannabis through locally integrated ecosystems. The company streamlines the patient experience from end-to-end, supporting the medical community in understanding medical cannabis and its treatment applications. Montu operates with partnerships for product innovation, regulatory compliance, and market development, with Germany and Australia as primary growth markets. No specific named products, modules, or distinct service offerings are explicitly identified in the available source material.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical cannabis access service
Companies that use Montu Group
Customer profileSegments1 record
Ideal customer profiles1 record
Montu Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Montu Group partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- International and Local PartnerscoreMontu has established international and local partnerships to remain at the forefront of market developments, including product innovation, regulatory changes, trends and latest research. These partnerships support the company's early-building of global support structure for emerging cannabis markets.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
Montu Group competitors and assessment
Company assessmentBroad incumbents
- Curaleaf Holdings: Large multi-state cannabis operator expanding internationally into European markets. Broad incumbent with similar patient-access and clinic-adjacent models, though primarily US-focused currently.
- Aurora Cannabis: Canadian-headquartered global cannabis producer and distributor with European medical cannabis operations. Broad incumbent comparable to Montu's medical cannabis distribution focus, particularly in European markets.
- Canopy Growth Corporation: Large Canadian cannabis operator with international medical cannabis distribution including Europe and Australia. Broad incumbent with overlapping patient-access capabilities in Montu's core markets, though at significantly larger scale.
- Tilray Brands: Global cannabis leader with major European and Australian operations across medical and adult-use segments. Broader incumbent comparable to Montu given significant footprint in both Germany and Australia, though operating at much larger scale with broader product portfolio.
Emerging players
- Zelira Therapeutics: Australian-listed medical cannabis company with proprietary formulations and patient-focused products. Emerging player comparable to Montu given Australian base and medical cannabis patient focus, though smaller scale and more product-development oriented.
Direct peers
- Creso Pharma: Australian-listed cannabis company with European operations targeting medical cannabis and wellness. Comparable to Montu given dual-region (Australia + Europe) footprint and medical cannabis patient focus.
- Little Green Pharma: Australian medical cannabis cultivator and distributor with patient access programs. Comparable to Montu in Australian market positioning, medical cannabis patient focus, and cross-jurisdiction ambitions.
- Demecan: Germany-based medical cannabis cultivator and distributor serving the German patient market. Direct comparable to Montu's German operations, sharing regulated medical cannabis distribution model in Montu's largest European growth market.
- Althea Group Holdings: Australian-headquartered medical cannabis company providing patient access via clinics and online platforms. Direct comparable to Montu given shared Australian origin, medical cannabis focus, and clinic-led patient model.
- Cannamedical Pharma: Germany-based medical cannabis distributor supplying pharmacies across Europe. Direct comparable to Montu given shared German market exposure and medical cannabis wholesale/distribution model targeting patient access.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Montu Group social profiles
Digital presenceMontu Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Montu Group leadership team
Management profileNumber of profiles
Profiles1 record
Montu Group funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Montu Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Montu Group
What does Montu Group do?
Montu Group facilitates access to medical cannabis products for patients through locally integrated ecosystems that streamline the end-to-end patient experience across Europe and Asia-Pacific markets. The company supports the medical community in understanding cannabis therapies, partners internationally and locally for product innovation and regulatory compliance, and operates with a long-term horizon in regulated cannabis markets, with Germany and Australia as its primary growth markets.
When was Montu Group founded?
Montu Group was founded in 2019. It employs 501 to 1,000 people.
Where is Montu Group based?
Montu Group is headquartered in Melbourne, Australia, in the Oceania region.
How does Montu Group make money?
One revenue line is on record: cannabis Product Sales.
Who are Montu Group's main competitors?
Broad incumbents on record are Curaleaf Holdings, Aurora Cannabis, Canopy Growth Corporation and Tilray Brands. Zelira Therapeutics is listed as an emerging player. Direct peers are Creso Pharma, Little Green Pharma, Demecan, Althea Group Holdings and Cannamedical Pharma.
Does Montu Group have an API?
No public API is recorded for Montu Group.
What industry is Montu Group in?
Montu Group's product category is Medical Cannabis. Its primary akta.pro industry code is CRANAFAB, Medical Cannabis Dispensaries, with a secondary code of CRANAGAG, Medical Cannabis Delivery & Online Ordering.